Recognition of pathogens by innate immunity;Rozpoznawanie patogenów przez wrodzony system odpornos̈ci

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 676-687

  Sochocka, Marta ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Autophagy; Innate immunity; NK cytotoxicity; TLRs

Indexed keywords

TOLL LIKE RECEPTOR;

DENDRITIC CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; NATURAL KILLER CELL; REVIEW; SIGNAL TRANSDUCTION;

DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 63149106110     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. Agaugue S., Marcenaro E., Ferranti B., Moretta L., Moretta A.: Human natural killer cells exposed to IL-2, IL-12, IL-18 or IL-4 differently modulate priming of native T cells by monocyte-derived dendritic cells. Blood, 2008; 112: 1776-1783
2. Akira S., Yamamoto M., Takeda K.: Role of adapters in Toll-like receptor signaling. Biochem. Soc. Trans., 2003; 31: 637-642
3. Arancibia S.A., Beltrán C.J., Aguirre I.M., Silva P., Peralta A.L., Malinarich F., Hermoso M.A.: Toll-like receptors are key participants in innate immune responses. Biol. Res., 2007; 40: 97-112
4. Arina A., Murillo O., Dubrot J., Azpilikueta A., Gabari I., Perez-Gracia J.L., Alfaro C., Berasain C., Prieto J., Ferrini S., Hervas-Stubbs S., Melero I.: Interleukin-15 liver gene transfer increases the number and function of IKDCs and NK cells. Gene Ther., 2008; 15: 473-483
5. Athiì MoralesV., O'Connor G.M., Gardiner C.M.: Activation of human NK cells by the bacterial pathogen-associated molecular pattern muramyl dipeptide. J. Immunol., 2008; 180: 4082-4089
6. Baetz A., Frey M., Heeg K., Dalpke A.H.: Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells. J. Biol. Chem., 2004; 279: 54708-54715
7. Bandyopadhaya A., Sarkar M., Chaudhuri K.: IL-1b expression in Int407 is induced by flagellin of Vibrio cholerae through TLR5 mediated pathway. Microb. Pathog., 2008; 44: 524-536
8. Barth H., Schnober E.K., Neumann-Haefelin C., Thumann C., Zeisel M.B., Diepolder H.M., Hu Z., Liang T.J., Blum H.E., Thimme R., Lambotin M., Baumert T.F.: Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol., 2008; 82: 3466-3479
9. Barton G.M.: A calculated response: control of inflammation by the innate immune system. J. Clin. Invest., 2008; 118: 413-420
10. Bas S., Neff L., Vuillet M., Spenato U., Seya T., Matsumoto M., Gabay C.: The proinflammatory cytokine response to Chlamydia trachomatis elementary bodies in human macrophages is partly mediated by a lipoprotein, the macrophage infectivity potentiator, through TLR2/TLR1/TLR6 and CD14. J. Immunol., 2008; 180: 1158-1168
11. Bach-Olszewska Z.: Innate immunity: cells, receptors, and signaling pathways. Arch. Immunol. Ther. Exp., 2005; 53: 245-253
12. Bach-Olszewska Z., Leszek J.: Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders. Neuropsychiatr. Dis. Treat., 2007; 3: 365-372
13. Bonmort M., Dalod M., Mignot G., Ullrich E., Chaput N., Zitvogel L.: Killer dendritic cells: IKDC and the others. Curr. Opin. Immunol., 2008; 20: 558-565
14. Brown M.G., Scalzo A.A.: NK gene complex dynamics and selection for NK cell receptors. Semin. Immunol., 2008; 20: 361-368
15. Bryceson Y.T., Long E.O.: Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol., 2008; 20: 344-352
16. Burgess S.J., Maasho M., Naravanan S., Borrego F., Coligan J. E.: The NKG2D receptor: immunobiology and clinical implications. Immunol. Res., 2008; 40: 18-34
17. Cambi A., Netea M.G., Mora-Montes H.M., Gow N.A., Hato S.V., Lowman D.W., Kullberg B.J., Torensma R., Williams D.L., Figdor C.G.: Dendritic cell interaction with Candida albicans critically depends on N-linked mannan. J. Biol. Chem., 2008; 283: 20590-20599
18. Caminschi I., Ahmet F., Heger K., Brady J., Nutt S.L., Vremec D., Pietersz S., Lahoud M.H., Schofield L., Hansen D.S., O'Keeffe M., Smyth M.J., Bedoui S., Davey G.M., Villadangos J.A., Heath W.R., Shortman K.: Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med., 2007; 204: 2579-2590
19. Chan C.W., Crafton E., Fan H.N., Flook J., Yoschimura K., Skarica M., Brockstedt D., Dubensky T.W., Stins M.F., Lanier L.L., Pardoll D.M., Housseau F.: Interferon-producing dendritic cells provide a link between innate and adaptive immunity. Nat. Med., 2006; 12: 207-213
20. Chan G., Guilbert L.J.: Ultraviolet-inactivated human cytomegalovirus induces placental syncytiotrophoblast apoptosis in a Toll-like receptor-2 and tumor necrosis factor-alpha dependent manner. J. Pathol., 2006; 210: 111-120
21. Chen X.M., Splinter P.L., O'Hara S.P., LaRusso N.F.: A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J. Biol. Chem., 2007; 282: 28929-28938
22. Chi H., Flavell R.A.: Innate recognition of non-self nucleic acids. Genome Biol., 2008; 9: 211
23. Dalpke A., Heeg K., Bartz H., Baetz A.: Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology, 2008; 213: 225-235
24. de Rham C., Ferrari-Lacraz S., Jendly S., Schneiter G., Dayer J.M., Villard J.: The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res. Ther., 2007; 9: R125
25. Degli-Esposti M.A., Smyth M.J.: Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol., 2005; 5: 112-124
26. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V.: Tolllike receptors control autophagy. EMBO J., 2008; 27: 1110-1121
27. Deretic V.: Autophagy in innate and adaptive immunity. Trends Immunol., 2005; 26: 523-528
28. Du Pasquier L.: Meeting the demand for innate and adaptive immunities during evolution. Scand. J. Immunol., 2005;62, Supp1: 39-48
29. Dunn S., Vohra R.S., Murphy J.E., Homer-Vanniasinkam S., Walker J.H., Ponnambalam S.: The lectin-like oxidized low-density-lipoprotein receptor: A pro-inflammatory factor in vascular disease., 2008; 409: 349-355
30. Dutertre C.A., Bonnin-Gélizé E., Pulford K., Bourel D., Fridman W.H., Teillaud J.L.: A novel subset of NK cells expressing high levels of inhibitory FcgRIIB modulating antibody-dependent function. J. Leukoc. Biol., 2008; 84: 1511-1520
31. Ferlazzo G.: Natural killer and dendritic cell liaison: recent insights and open questions. Immunol. Lett., 2005; 101: 12-17
32. Ferlazzo G.: Isolation and analysis of human natural killer cell subsets. Methods Mol. Biol., 2008; 415: 197-213
33. Fitzgerald-Bocarsly P., Dai J., Singh S.: Plasmocytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev., 2008; 19: 3-19
34. Granucci F., Zanoni I., Ricciardi-Castagnoli P.: Central role of dendritic cells in the regulation and deregulation of immune responses. Cell. Moll. Life Sci., 2008; 65: 1683-1697
35. Grassmann R., Jeang K.T.: The roles of microRNAs in mammalian virus infection. Biochim. Biophys. Acta, 2008; 1779: 706-711
36. Guo Y., Chen J., Zhao T., Fan Z.: Granzyme K degrades the redox/DNA repair enzyme Ape1 to trigger oxidative stress cells leading to cytotoxicity. Mol. Immunol., 2008; 45: 2225-2235
37. Han X., Fan Y., Wang S., Jiao L., Qiu H., Yang X.: NK cells contribute to intracellular bacterial infection-mediated inhibition of allergic responses. J. Immunol., 2008; 180: 4621-4628
38. Hara H., Ishihara C., Takeuchi A., Xue L., Morris S.W., Penninger J.M., Yoshida H., Saito T.: Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9. J. Immunol., 2008; 181: 918-930
39. Harvey B.P., Quan T.E., Rudenga B.J., Roman R.M., Craft J., Mamula M.J.: Editing antigen presentation: antigen transfer between human B lymphocytes and macrophages mediated by class A scavenger receptors. J. Immunol., 2008; 181: 4043-4051
40. Hazen S.L.: Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem., 2008; 283: 15527-15531
41. Heib V., Becker M., Taube C., Stassen M.: Advances in the understanding of mast cell function. Br. J. Hematol., 2008; 142: 683-694
42. Jeannin P., Jaillon S., Delneste Y.: Pattern recognition receptors in the immune response against dying cells. Curr. Opin. Immunol., 2008; 20: 530-537
43. Jiang Q., Wei H., Tian Z.: IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma. J. Immunother., 2008; 31: 555-562
44. Jonjiæ S., Babiæ M., Poliæ B., Krmpotiæ A.: immune evasion of natural killer cells by viruses. Curr. Opin. Immunol., 2008; 20: 30-38
45. Kawai T., Akira S.: TLR signaling. Cell Death Differ., 2006; 13: 816-825
46. Kawai T., Akira S.: TLR signaling., Semin. Immunol., 2007; 19: 24-32
47. Kawai T., Akira S.: Antiviral signaling through pattern recognition receptors. J. Biochem., 2007; 141: 137-145
48. Kawai T., Akira S.: Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med., 2007; 13: 460-469
49. Kijima M., Yamaguchi T., Ishifune C., Maekawa Y., Koyanagi A., Yagita H., Chiba S., Kishihara K., Shimada M., Yasumoto K.: Dendritic cellmediated NK cell activation is controlled by Jagged2-Notch interaction. Proc. Natl. Acad. Sci. USA, 2008; 105: 7010-7015
50. Knapp S., von Aulock S., Leendertse M., Haslinger I., Draing C., Golenbock D.T., van der Poll T.: Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J. Immunol., 2008; 180: 3478-3484
51. Kopeæ-Szlêzak J., Podstawka U.: Biologia komórek NK (Natural Killer). Onkol. Pol., 2007; 10/3: 115-119
52. Koval'chuk L.V., Khoreva M.V., Varivoda A.S., Pashchenko O.E., Gracheva L.A., Bykova L.P., Kondratenko I.V., Bologov A.A.: Analysis of Toll-like receptor-dependent production of proinflammatory cytokines in vitro by human peripheral blond mononuclears of donors and patients with primary immunodeficiency. Bull. Exp. Biol. Med., 2007; 144: 63-65
53. Krzewski K., Chen X., Strominger J.L.: WIP is essential for lytic granule polarization and NK cell cytotoxicity. Proc. Natl. Acad. Sci. USA, 2008; 19,105: 2568-2573
54. Lanier L.L.: Evolutionary struggles between NK cells and viruses. Nat. Rev. Immunol., 2008; 8: 259-268
55. Linehan S.A.: The mannose receptor is expressed by subsets of APC in non-lymphoid organs. BMC Immunology, 2005; 6: 4
56. Lodish H.F., Zhou B., Liu G., Chen C.Z.: Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol., 2008; 8: 120-130
57. Majewska M., Szczepanik M.: Rola receptorów toll-podobnych (TLR) w odpornoci wrodzonej i nabytej oraz ich funkcja w regulacji odpowiedzi immunologicznej. Post. Hig. Med. Dow., 2006; 60: 52-63
58. Malmberg K.J., Bryceson Y.T., Carlsten M., Andersson S., Björklund A., Björkström N.K., Bauman B.C., Fauriat C., Alici E., Dilber M.S., Ljunggren H.G.: NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer. Immunol. Immunother., 2008; 57: 1541-1552
59. Mandelboim O.M.: Virus and tumour recognition by the natural cytotoxicity receptors. Immunology, 2004; 113(Supp.1): 14-16
60. Martinez-Borra J., Khakoo S.I.: Speed and selection in the evolution of killer cell immunoglobulin-like receptors. Int. J. Immunogenet., 2008; 35: 89-96
61. Marttila-Ichihara F., Turja R., Miiluniemi M., Karikoski M., Maksimov M., Niemelä J., Martinez-Pomares L., Salmi M., Jalkanen S.: Macrophage mannose receptor on lymphatic controls cell trafficking. Blood, 2008; 112: 64-72
62. Matsumoto M., Seya T.: TLR3: interferon induction by double stranded RNA including poly (I:C). Adv. Drug. Deliv. Rev., 2008; 60: 805-812
63. Medzhitov R.: Recognition of microorganisms and activation of the immune response. Nature., 2007; 449: 819-826
64. Mezger M., Kneitz S., Wozniok I., Kurzai O., Einsele H., Loeffer J.: Proinflammatory response of immature human dendritic cells in mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes., J. Infect. Dis., 2008; 197: 924-931
65. Miller J.L., Dewet B.J., Martinez-Pomares L., Radcliffe C.M., Dwek R.A., Rudd P.M., Gordon S.: The mannose receptor mediates dengue virus infection of macrophages. PLoS. Pathol., 2008; 4: e17
66. Misch E.A., Hawn T.R.: Toll-like receptor polymorphisms and susceptibility to human disease. Clinical Science, 2008; 114: 347-360
67. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., Moretta A.: Effector and regulatory events during natural killer-dendritic cell interactions. Immunol. Rev., 2006; 214: 219-228
68. Morrison L.A.: The Toll of herpes simplex virus infection. Trends Microbiol., 2004; 12: 353-356
69. Nieland T.J., Shaw J.T., Jaipuri F.A., Duffner J.L., Koehler A.N., Banakos S., Zannis V.I., Kirchhausen T., Krieger M.: Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity. Biochemistry, 2008; 47: 460-472
70. Nyman T., Stenmark P., Flodin S., Johansson I., Hammarstrõm M., Nordlund P.: The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J. Biol. Chem., 2008; 283: 11861-11865
71. Pallandre J.R., Krzewski K., Bedel R., Ryffel B., Caignard A., Rohrlich P.S., Pivot X., Tiberghien P., Zitvogel L., Strominger J.L., Borg C.: Dendritic cell and natural killer cell cross-talk: A pivotal role of CX3CL1 in NK cytoskeleton organization and activation. Blood, 2008; 112: 4420-4424
72. Peiser M., Koeck J., Kirsching C.J., Wittig B., Wanner R.: Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+ T cell stimulatory capacity. J. Leukoc. Biol., 2008; 83:1118-1127
73. Plattner F., Yarovinsky F., Romero S., Didry D., Carlier M.F., Sher A., Soldati-Favre D.: Toxoplasma profiling is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell. Host. Microbe., 2008; 3: 77-87
74. Randolph G.J., Ochando J., Partida-Sanchez S.: Migration of dendritic cell subsets and their precursors. Annu. Rev. Immunol., 2007; 26: 293-316
75. Rubstov A.V., Swanson C.L., Troy S., Strauch P., Pelanda R., Torres R.M.: TLR agonists promote marginal zone B cell activation and facilitate T-dependent IgM responses. J. Immunol., 2008; 180: 3882-3888
76. Sall A., Liu Z., Zhang H.M., Yuan J., Lim T., Su Y., Yang D.: MicroRNAs-based therapeutic strategy for virally induced diseases. Curr. Drug. Discov. Technol., 2008; 5: 49-58
77. Sawada S., Harada K., Isse K., Sato Y., Sasaki M., Kaizaki Y., Nakanuma Y.: Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction. Pathol. Int., 2007; 57: 652-653
78. Schoenberg K., Trompeter H.I., Uhrberg M.: Delivery of DNA into natural killer cells for immunotherapy. Methods Mol. Biol., 2008; 423: 165-172
79. Scott G.B., Meade J.L., Cook G.P.: Profiling killers; unraveling the pathways of human natural killer cell function. Brief. Funct. Genomic. Proteomic., 2008; 7: 8-16
80. Shah V.B., Huang Y., Keshwara R., Ozment-Skelton T., Williams D.L., Keshvara L.: β-glucan activates microglia without including cytokine production in Dectin-1-dependent manner. J. Immunol., 2008; 180: 2777-2785
81. Shehata M.A., Abou El-Enein A., El-Sharnouby G.A.: Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection. Egypt. J. Immunol., 2006; 13: 141-152
82. Shibolet O., Podolsky D.K.: TLRs in the Gut. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subscription. Am. J. Physiol. Gastrointest. Liver Physiol., 2007; 292: G1469-G1473
83. Smyth M.J., Hayakawa Y., Takeda K., Yagita H.: New aspects of natural killer cell survivalence and therapy of cancer. Nat. Rev. Cancer, 2002; 2: 850-861
84. Snelgrove R., Gwyer E., Hussell T.: Modulation of immunity to respiratory viral infection. Future Virol., 2006; 1: 471-481
85. Sochocka M., Bach-Olszewska Z.: Mechanizmy wrodzonej odpornoci. Post. Hig Med Dow., 2005; 59: 250-258
86. Sonkoly E., Stahle M., Pivarcsi A.: MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin. Cancer Biol., 2008; 18: 131-140
87. Sonkoly E., Stahle M., Pivarcsi A.: MicroRNAs: novel regulators in skin inflammation. Clin. Exp. Dermatol., 2008; 33: 312-315
88. Spadaro M., Caorsi C., Ceruti P., Varadhachary A., Forni G., Pericle F., Giovarelli M.: Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells. FASEB J., 2008; 22: 2747-2757
89. Stêpieñ A., Izdebska M., Grzanka A.: Rodzaje mierci komórki. Post. Hig. Med. Dow., 2007; 61: 420-428
90. Sun Y., Shu R., Zhang M.Z., Wu A.P.: Toll-like receptor 4 signaling plays a role in triggering periodontal infection. FEMS Immunol. Med. Microbiol., 2008; 52: 362-369
91. Takaoka A., Wang Z., Choi M.K., Yanai H., Negishi H., Ban T., Lu Y., Miyagishi M., Kodama T., Honda K., Ohba Y., Taniguchi T.: DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature, 2007; 448: 501-505
92. Takeuchi O., Akira S.: Recognition of viruses by innate immunity. Immunol. Rev., 2007; 220: 214-224
93. Takeuchi O., Akira S.: MDA5/RIG-I and virus recognition. Curr. Opin. Immunol., 2008; 20: 17-22
94. Tarleton R.L.: Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol., 2007; 19: 430-434
95. Thomson R.C., Petrik J., Nash A.A., Dutia B.M.: Expansion and activation of NK cell populations in a gammaherpesvirus infection. Scand. J. Immunol., 2008; 67: 489-495
96. Tipping P.G.: Toll-like receptors: The interface between innate and adaptive immunity. J. Am. Soc. Nephrol., 2006; 17: 1769-1771
97. Togbe D., Schofield L., Grau G.E., Schnyder B., Boissay V., Charron S., Rose S., Beutler B., Quesniaux V.F., Ryffel B.: Murine cerebral malaria development is independent of toll-like receptor signaling. Am. J. Pathol., 2007; 170: 1640-1648
98. Tokarz-Deptu.a B., Nied.wiedzka P., Deptu.a W.: Receptory Toll-podobne . nowe znaczniki w immunologii. Alergia Astma Immunologia, 2006; 11: 23-28
99. Torrelles J.B., Azad A.K., Henning L.N., Carlson T.K., Schlesinger L.S.: Role of the C-type lectins in mycobacterial infection. Curr. Drug Targets, 2008; 9: 102-112
100. Trujillo J.R., Rogers R., Molina R.M., Dangond F., McLane M.F., Essex M.F., Brain J.D.: Noninfectious entry of HIV-1 into peripheral and brain macrophages mediated by the mannose receptor. Proc. Natl. Acad. Sci. USA, 2007; 104: 5097-5102
101. Tulic M.K., Hurrelbrink R.J., Prele C.M., Laing I.A., Upham J.W., Le Souef P., Sly P.D., Holt P.G.: TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolisaccharide. J. Immunol., 2007; 179: 132-140
102. Uematsu S., Akira S.: Toll-like receptors and innate immunity. J. Mol. Med., 2006; 84: 712-725
103. Vahlne G., Becker S., Brodin P., Johansson M.H.: IFN-g production and degranulation are differentially regulated in response to stimulation in murine natural killer cells. Scand. J. Immunol., 2008; 67: 1-11
104. Vilen B.J., Rutan J.A.: The regulation of autoreactive B cells during innate immune response. Immunol. Res., 2008; 41: 295-309
105. Vosshenrich C.A., Lesjean-Pottier S., Hasan M., Richard-Le Goff O., Corcuff E., Mandelboim O., Di Santo J.P.: CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med., 2007; 204: 2569-2578
106. Vremec D., O'Keeffe M., Hochrein H., Fuschberger M., Caminschi I., Lahoud M., Shortman K.: Production of interferons by dendritic cells, plasmocytoid cells, natural killer cells and interferon-producing killer dendritic cells. Blood, 2007; 109: 1165-1173
107. Weiss J.M., Subleski J.J., Wigginton J.M., Wiltrout R.H.: Immunotherapy of cancer by IL-12 based cytokine combinations. Expert. Opin. Biol. Ther., 2007; 7: 1705-1721
108. Willment J.A., Brown G.D.: C-type lectin receptors in antifungal immunity. Trends. Microbiol., 2008; 16: 27-32
109. Wilson N.S., Young L.J., Kupresanin F., Naik S.H., Vremec D., Heath W.R., Akira S., Shortman K., Boyle J., Maraskovsky E., Belz G.T., Villadangos J.A.: Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Tolllike receptor signaling. Immunol. Cell Biol., 2008; 86: 200-2005
110. Yokoyama W., Colonna M.: Innate immunity to pathogens. Curr. Opin. Immunol., 2008; 20: 1-2
111. Yokoyama W.M., Riley J.K.: NK cells and their receptors. Reprod. Biomed., 2008; 16: 173-191
112. Yoshimura A., Naka T., Kubo M.: SOCS proteins, cytokine signaling and immune regulation. Nat. Rev. Immunol, 2007; 7: 454-465
113. Zeytun A., van Velkinburgh J.C., Pardington P.E., Cary R.R., Gupta G.: Pathogen-specific innate immune response. Adv. Exp. Med. Biol., 2007; 598: 342-357
114. Zhang C., Zhang J., Niu J., Zhang J., Tian Z.: Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Cytokine, 2008; 42: 128-136
115. Zhang S.Y., Jouanguy E., Sancho-Schimizu V., von Bernuth H., Yang K., Abel L., Picard C., Puel A., Casanova J.L.: Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol. Rev., 2007; 220: 225-236
116. Zhong M., Kadota Y., Shimizu Y., Gohda E.: Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and E. Int. Immunopharmacol., 2008; 8: 508-513